Bausch Health Companies Inc. Earnings Per Share Disclosure
| (in millions, except per share amounts) | 2025 | 2024 | 2023 | |||||||||||||||||
| Net income (loss) attributable to Bausch Health Companies Inc. | $ | 157 | $ | (46) | $ | (592) | ||||||||||||||
| Basic weighted-average common shares outstanding | 370.9 | 368.0 | 364.9 | |||||||||||||||||
| Diluted effect of stock options and RSUs | 4.1 | — | — | |||||||||||||||||
| Diluted weighted-average common shares outstanding | $ | 375.0 | $ | 368.0 | $ | 364.9 | ||||||||||||||
| Earnings (loss) per share attributable to Bausch Health Companies Inc. | ||||||||||||||||||||
| Basic | $ | 0.42 | $ | (0.13) | $ | (1.62) | ||||||||||||||
| Diluted | $ | 0.42 | $ | (0.13) | $ | (1.62) | ||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 19, 2026 | Showing above |
| 2019 | Feb 19, 2020 | |
| 2018 | Feb 20, 2019 | |
| 2017 | Feb 28, 2018 | |
| 2016 | Mar 1, 2017 | |
| 2015 | Apr 29, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.